Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Yoshimasu

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Allergology International : Official Journal of the Japanese Society of Allergology|November 26, 2013
Eradication therapy for urticaria with high titers of anti H. pylori IgG antibodyTakashi Yoshimasu, Fukumi Furukawa
Autoimmunity Reviews|March 3, 2016
Modified immunotherapy for alopecia areataTakashi Yoshimasu, Fukumi Furukawa
Autoimmunity Reviews|August 6, 2005
Animal models of spontaneous and drug-induced cutaneous lupus erythematosusFukumi Furukawa, Takashi Yoshimasu
Cureus|February 3, 2025
Estimating Future Obstetrics and Gynecology Workforce Needs in JapanTakashi Yoshimasu, Tasuku Inao, Isao Yokota
Cureus|December 31, 2025
Treatment Effects of Genital Mycoplasma Species in High-Risk Pregnant Individuals: A Retrospective Cohort StudyTakashi Yoshimasu, Tasuku Inao, Tetsuya Kawakita
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|September 7, 2010
[Pathogenesis of cutaneous lupus erythematosus from LE-prone mice]Fukumi Furukawa, Takashi Yoshimasu, Nobuo Kanazawa
The Journal of Dermatology|April 21, 2016
Multiple courses of pulse corticosteroid therapy for alopecia areataTakashi Yoshimasu, Nobuo Kanazawa, Yuki Yamamoto, et al.
Autoimmunity Reviews|January 24, 2009
Mast cells and histamine metabolism in skin lesions from MRL/MP-lpr/lpr miceFukumi Furukawa, Takashi Yoshimasu, Yuki Yamamoto, et al.
Journal of Dermatological Science|May 15, 2002
Comparison of anti 60 and 52 kDa SS-A/Ro antibodies in the pathogenesis of cutaneous lupus erythematosusTakashi Yoshimasu, Akihisa Hiroi, Toshio Ohtani, et al.
European Journal of Dermatology : EJD|January 26, 2002
Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositisTakashi Yoshimasu, Toshio Ohtani, Taiko Sakamoto, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Allergology International : Official Journal of the Japanese Society of Allergology|November 26, 2013
Eradication therapy for urticaria with high titers of anti H. pylori IgG antibodyTakashi Yoshimasu, Fukumi Furukawa
Autoimmunity Reviews|March 3, 2016
Modified immunotherapy for alopecia areataTakashi Yoshimasu, Fukumi Furukawa
Autoimmunity Reviews|August 6, 2005
Animal models of spontaneous and drug-induced cutaneous lupus erythematosusFukumi Furukawa, Takashi Yoshimasu
Cureus|February 3, 2025
Estimating Future Obstetrics and Gynecology Workforce Needs in JapanTakashi Yoshimasu, Tasuku Inao, Isao Yokota
Cureus|December 31, 2025
Treatment Effects of Genital Mycoplasma Species in High-Risk Pregnant Individuals: A Retrospective Cohort StudyTakashi Yoshimasu, Tasuku Inao, Tetsuya Kawakita
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|September 7, 2010
[Pathogenesis of cutaneous lupus erythematosus from LE-prone mice]Fukumi Furukawa, Takashi Yoshimasu, Nobuo Kanazawa
The Journal of Dermatology|April 21, 2016
Multiple courses of pulse corticosteroid therapy for alopecia areataTakashi Yoshimasu, Nobuo Kanazawa, Yuki Yamamoto, et al.
Autoimmunity Reviews|January 24, 2009
Mast cells and histamine metabolism in skin lesions from MRL/MP-lpr/lpr miceFukumi Furukawa, Takashi Yoshimasu, Yuki Yamamoto, et al.
Journal of Dermatological Science|May 15, 2002
Comparison of anti 60 and 52 kDa SS-A/Ro antibodies in the pathogenesis of cutaneous lupus erythematosusTakashi Yoshimasu, Akihisa Hiroi, Toshio Ohtani, et al.
European Journal of Dermatology : EJD|January 26, 2002
Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositisTakashi Yoshimasu, Toshio Ohtani, Taiko Sakamoto, et al.
Pageof 3